Skip to main content

Advertisement

SpringerLink
Log in

X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Afar DEH, Park H, Howell BW, Rawlings DJ, Cooper J, Witte ON (1996) Regulation of Btk by Ste family tyrosine kinases. Mol Cell Biol 16:3465

    Google Scholar 

  2. Anderson IS, Teutsch M, Dong Z, Wortis HH (1996) An essential role for tyrosine kinase in the regulation of Bruton's B-cell apoptosis. Proc Natl Acad Sci USA 93:10966

    Google Scholar 

  3. Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL (1997) Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 385:93

    Google Scholar 

  4. Aoki Y, Isselbacher KJ, Pillai S (1994) Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci USA 91:10606

    Google Scholar 

  5. Ashida ER, Saxon A (1986) Home intravenous immunoglobulin therapy by self-administration. J Clin Immunol 6:306

    Google Scholar 

  6. Berglöf A, Sandstedt K, Feinstein R, Bölske G, Smith CIE (1996) B cell deficient μMT mice as an experimental model for Mycoplasma infections in X-linked agammaglobulinemia. Eur J Immunol 27:2118

    Google Scholar 

  7. Björkander J, Cunningham-Rundles C, Lundin P, Olsson R, Söderström R, Hanson L-A (1988) Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 84:107

    Google Scholar 

  8. Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T (1994) Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 331:1607

    Google Scholar 

  9. Blaese RM, Culver KW, Miller AD, et al (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475

    Google Scholar 

  10. Bolen JB (1995) Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr Opin Immunol 7:306

    Google Scholar 

  11. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470

    Google Scholar 

  12. Bruton OC (1952) Agammaglobulinemia. Pediatrics 9:722

    Google Scholar 

  13. Campana D, Farrant J, Inamdar N, Webster ADB, Janossy G (1990) Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol 145:1675

    Google Scholar 

  14. Conley ME, Puck JM (1988) Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr 112:688

    Google Scholar 

  15. Conley ME, Brown P, Pickard AR, Buckley RH, Miller DS, Raskind WH, Singer JW, Fialkow PJ (1986) Expression of the gene defect in X linked agammaglobulinemia. N Engl J Med 315:564

    Google Scholar 

  16. Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J (1994) Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 3:1751

    Google Scholar 

  17. Cooper, MD, Lawton AR (1972) Circulating B-cells in patients with immunodeficiency. Am J Pathol 69:513

    Google Scholar 

  18. Cory GOC, Lovering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinsky RJ, Kinnon C (1995) The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med 182:611

    Google Scholar 

  19. Dalakas MC (1994) High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 44:223

    Google Scholar 

  20. De Weers M, Brouns GS, Hinshelwood S, Kinnon C, Schuurman RKB, Hendriks RW, Borst J (1994) B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J Biol Chem 269:23857

    Google Scholar 

  21. De Weers M, Mensink RGJ, Kraakman MEM, Schuurman RKB, Hendriks RW (1994) Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Hum Mol Genet 3:161

    Google Scholar 

  22. Evengård B, Sandstedt K, Bölske G, Feinstein R, Riesenfelt-Öm I, Smith CIE (1994) Intranasal inoculation ofMycoplasma pulmonis in mice with severe combined immunodeficiency (scid) causes a wasting disease with grave arthritis. Clin Exp Immunol 98:388

    Google Scholar 

  23. Fearon ER, Winkelstein JA, Civin CI, Pardoll D, Vogelstein B (1987) Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med 316:427

    Google Scholar 

  24. Ferguson KM, Lemmon MA, Schlessinger J, Sigler PB (1995) Structure of the high affinity complex of inositol triphosphate with a phospholipase C pleckstrin homology domain. Cell 83:1037

    Google Scholar 

  25. Fröland S, Natvig JB, Berdal P (1971) Surface-bound immunoglobulins as a marker of B lymphocytes in man. Nature 234:251

    Google Scholar 

  26. Fukuda M, Kojima T, Kabayama H, Mikoshiba K (1996) Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J Biol Chem 271:30303

    Google Scholar 

  27. Gardulf A, Hammarström L, Smith CIE (1991) Home treatment of hypogammaglobulinemia with subcutaneous gammaglobulin by rapid infusions. Lancet 338:162

    Google Scholar 

  28. Gardulf A, Björvell H, Gustafson R, Hammarström L, Smith CIE. The life situation in patients with primary antibody deficiency-untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol 92:200

  29. Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G, Nyström T, Søeberg B, Smith CIE (1995) Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 345:365

    Google Scholar 

  30. Gelfand EW (1993) Unique susceptibility of patients with antibody deficiency to Mycoplasma infection. Clin Infect Dis 17[suppl]:250

    Google Scholar 

  31. Grey HM, Rabellino E, Pirofsky B (1971) Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest 50:2368

    Google Scholar 

  32. Hagemann TL, Chen Y, Rosen FS, Kwan S-P (1994) The genomic structure of the BTK gene and its use in direct DNA sequence analysis for mutations in patients with X-linked agammaglobulinemia. Hum Mot Genet 3:1743

    Google Scholar 

  33. Haire RN, Ohta Y, Lewis JE, Fu SM, Kroisel P, Litman GW (1994) TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tee family kinases and maps to 4p12. Hum Mol Genet 3:897

    Google Scholar 

  34. Hansson H, Mattsson PT, Allard P, Hapaniemi P, Vihinen M, Smith CIE, Härd T (1998) Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37: 2912

    Google Scholar 

  35. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW (1994) Pleckstrin homology domains bind to phosphatidylinositol-4, 5-bisphosphate. Nature 371:168

    Google Scholar 

  36. Hashimoto S, Tsukada S, Matsushita M et al (1996) Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 88:561

    Google Scholar 

  37. Hendriks RW, Bruijn MFTR de, Maas A, Dingjan GM, Karis A, Grosveld F (1996) Inactivation of Btk by insertion ofIacZ reveals defects in B cell development past the pre-B cell stage. EMBO J 15:4862

    Google Scholar 

  38. Hermaszewski RA, Webster ADB (1993) Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86:31

    Google Scholar 

  39. Himmelmann A, Thevenin C, Harrison K, Kehrl JH (1996) Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SpI sites. Blood 87:1036

    Google Scholar 

  40. Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, Vihinen M, Götz G, Hubbard SR, Belobradsky BH, Smith CIE Meindl A (1998) Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics 101: 276

    Google Scholar 

  41. Hyvönen M, Saraste M (1997) Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinemia. EMBO J 16:3396

    Google Scholar 

  42. Janeway CA, Apt L, Gitlin D (1953) Agammaglobulinemia. Trans Assoc Am Physicians 66:200

    Google Scholar 

  43. Kawakami Y, Miura T, Bissonnette R, Hata D, Khan WN, Kitamura T, Maeda-Yamamoto M, Hartman SE, Yao L (1997) Alt FW Kawakami T. Bruton's tyrosine kinase regulates apoptosis and JNK/SAPK kinase activity. Proc Natl Acad Sci USA 94:3938

    Google Scholar 

  44. Kerner JD, Appleby MW, Mohr RN, Chien S, Rawlings DJ, Maliszewski CR, Witte ON, Perlmutter RM (1995) Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301

    Google Scholar 

  45. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Müller S, Kantor AB, Herzenberg LA, Rosen FS, Sideras P (1995) Defective B-cell development and function in Btk-deficient mice. Immunity 3:283

    Google Scholar 

  46. Kurosaki T, Kurosaki M (1997) Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J Biol Chem 272:15595

    Google Scholar 

  47. Lappalainen I, Ollila J, Smith CIE, Vihinen M (1997) Registries of immunodeficiency patients and mutations. Hum Mutation 10:261

    Google Scholar 

  48. Lederman HM, Winkelstein JA (1985) X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 64: 145

    Google Scholar 

  49. Lever AML, Webster ADB, Brown D, Thomas HC (1984) Non-A, non-B hepatitis occuring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet 11:1062

    Google Scholar 

  50. Li T, Tsukada S, Satterthwaite A, Havlik MH, Park H, Takatsu K, Witte ON (1995) Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2:451

    Google Scholar 

  51. Liese JG, Wintergerst U, Tympner KD, Belohradsky BH (1992) High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am J Dis Child 146:335

    Google Scholar 

  52. Lyon MF (1966) X-chromosome inactivation in mammals. Adv Teratol 1:25

    Google Scholar 

  53. Mano H, Ishikawa F, Nishida J, Hara H, Takaku F (1990) A novel protein-tyrosine kinase, tec, is preferentially expressed in the liver. Oncogene 5:1781

    Google Scholar 

  54. Matsuda T, Takahashi-Tezuka M, Fukada T, Okuyama Y, Fujitani Y, Tsukada S, Mano H, Hirai H, Witte ON, Hirano T (1995) Association and activation of Btk and Tec tyrosine kinases by gpl30, a signal transducer of the IL-6 family of cytokines. Blood 85:627

    Google Scholar 

  55. Mattsson PT, Vihinen M, Smith CIE (1996) X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. BioEssays 18:825

    Google Scholar 

  56. McKinney RE Jr, Katz SL, Wilfert CM (1987) Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9:334

    Google Scholar 

  57. Misbah SA, Spickett GP, Ryba PIC, Hockaday JM, Kroll JS, Sherwood C, Kurtz JB, Moxon ER, Chapel HM (1992) Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and review of the literature. J Clin Immunol 12:266

    Google Scholar 

  58. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT (1996) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385:650

    Google Scholar 

  59. Müller S, Sideras P, Smith CIE, Xanthopoulos KG (1996) Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase (Btk) gene is regulated by Spl- and Spi-l/PU.l- family members. Oncogene 13:1955

    Google Scholar 

  60. Naor D, Bentwich Z, Cividalli G (1969) Inability of peripheral lymphoid cells of agammaglobulinaemic patients to bind radioiodinated albumins. Aust J Exp Biol Med Sci 47:759

    Google Scholar 

  61. Notarangelo LD, Peitsch MC, Abrahamsen TG, et al (1996) CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 17: 511

    Google Scholar 

  62. Ochs HD, Smith CIE (1996) X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine 75:287

    Google Scholar 

  63. Ochs HD, Fisher SH, Virant FS, Lee ML (1985) Non-A, non-B hepatitis after intravenous immunoglobulin. Lancet 1:322

    Google Scholar 

  64. Oeltjen JC, Liu X, Lu J, Allen RC, Muzny D, Belmont JW, Gibbs RA (1995) Sixty-nine kilobases of contiguous human genomic sequence containing the alpha-galactosidase A and Bruton's tyrosine kinase loci. Mamm Genome 6:334

    Google Scholar 

  65. Oeltjen JC, Malley TM, Muzny DM, Miller W, Gibbs RA, Belmont JW (1997) Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. Genome Res 7:315

    Google Scholar 

  66. Ohta Y, Haire RN, Litman RT, Fu SM, Nelson RP, Kratz J, Kornfeld SJ, Morena M de la, Good RA, Litman GW (1994) Genomic organisation and structure of Bruton agammaglobulinemia tyrosine kinase: localisation of mutations associated with varied clinical presentations and course in X-linked agammaglobulinemia. Proc Natl Acad Sci USA 91:9062

    Google Scholar 

  67. Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet Jean-P, Witte ON (1996) Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4:515

    Google Scholar 

  68. Pawson T (1995) Protein modules and signalling networks. Nature 373:573

    Google Scholar 

  69. Puck JM, De Saint Basile G, Schwarz K, Fugmann S, Fischer RE (1996) IL2RGbase: a database of gc defects causing human X-linked SCID. Immunol Today 17:507

    Google Scholar 

  70. Rawlings DJ, Witte ON (1995) The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function. Semin Immunol 7:237

    Google Scholar 

  71. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, Jenkins NA, Witte ON (1993) Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358

    Google Scholar 

  72. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP (1996) Activation of BTK by a phosphorylation mechanism initiated by Src family kinases. Science 271:822

    Google Scholar 

  73. Rohrer J, Parolino O, Belmont JW, Conley ME (1994) The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia. Immunogenetics 40:319

    Google Scholar 

  74. Roos D, Cumutte JT, Hossle H-P, Lau YL, Ariga T, Nunoi H, Dinauer MC, Gahr M, Segal AW, Newburger PE, Giacca M, Keep NH, Zwieten R van (1996) X-CGD-base: a database of X-CGD-causing mutations. Immunol Today 17:517

    Google Scholar 

  75. Rudge P, Webster ADB, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N (1996) Encephalomyelitis in primary hypogammaglobulinaemia. Brain 119:1

    Google Scholar 

  76. Salim K, Bottomley MJ, Querfurth E, Zvelebil MJ, Gout I, Scaife R, Margolis RL, Gigg R, Smith CIE, Driscoll PC, Waterfield MD, Panayotou G (1996) Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 15: 6241

    Google Scholar 

  77. Samuelson A, Borrelli S, Gustafson R, Hammarström L, Smith CIE, Jonasson J, Lindberg AA (1995) Characterization ofHaemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations. Scand J Infect Dis 27: 303

    Google Scholar 

  78. Sandstedt K, Berglöf A, Feinstein R, Bölske G, Evengård B, and Smith CIE (1997) Differential susceptibility toMycoplasma pulmonis intranasal infection in X-linked immunodeficient (xid), severe combined immunodeficient (scid), and immunocompetent mice. Clin Exp Immunol 108:490

    Google Scholar 

  79. Saouaf SJ, Mahajan S, Rowley RB, Kut S, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON, Bolen JB (1994) Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinase following B cell antigen receptor surface engagement. Proc Natl Acad Sci USA 91:9524

    Google Scholar 

  80. Sato S, Katagiri T, Takaki S, Kikuchi Y, Hitoshi Y, Yonehara S, Tsukada S, Kitamura D, Watanabe T, Witte O, Takatsu K (1994) IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 180:2101

    Google Scholar 

  81. Scher I (1982) The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol 33:1

    Google Scholar 

  82. Schwarz K, Nonoyama S, De Saint Basile G, et al (1996) WASPbase: a Database of Wiskott-Aldrich-Syndrome (WAS) and X-linked thrombocytopenia (XLT) causing mutations. Immunol Today 17:496

    Google Scholar 

  83. Sicheri F, Moarefi I, Kuriyan J (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385:602

    Google Scholar 

  84. Sideras P, Smith CIE (1995) Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 59:135

    Google Scholar 

  85. Sideras P, Muller S, Shiels H, et al (1994) Genomic organisation of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J Immunol 153:5607

    Google Scholar 

  86. Siegal FP, Perms B, Kunkel HG (1971) Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol 1:482

    Google Scholar 

  87. Smith CIE, Notarangelo LD (1997) Molecular basis for X-linked immunodeficiencies. Adv Genet 35:57

    Google Scholar 

  88. Smith CIE, Vihinen M (1996) Immunodeficiency mutation databases — a new research tool. Immunol Today 17:495

    Google Scholar 

  89. Smith CIE, Witte ON (1998) X-linked agammaglobulinemia. A disease of the Btk tyrosine kinase. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases. A genetic and molecular approach. Oxford University Press, Oxford (in press)

    Google Scholar 

  90. Smith CIE, Baskin B, Humire-Greiff P, et al (1994) Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152:557

    Google Scholar 

  91. Smith CIE, Islam KB, Vorechovsky I, Olerup O, Wallin E, Rabbani H, Baskin B, Hammarström L (1994) X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev 138:159

    Google Scholar 

  92. Takata M, Kurosaki T (1996) A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J Exp Med 184:31

    Google Scholar 

  93. Thomas JD, Sideras P, Smith CIE, Vorechovsky I, Chapman V, Paul WE (1993) A missense mutation in the X-linked agammaglobulinemia gene colocalizes with the mouse X-linked immunodeficiency gene. Science 261:355

    Google Scholar 

  94. Tsukada S, Simon M, Witte O, Katz A (1994) Binding of the b subunits of heterotrimeric G-proteins to the PH domain of Bruton's tyrosine kinase. Proc Natl Acad Sci USA 91:11256

    Google Scholar 

  95. Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J, Kurosaki T (1996) BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273:1096

    Google Scholar 

  96. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarström L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR (1993) The gene involved in X-linked agammaglobulinemia is a member of the Ste family of protein-tyrosine kinases. Nature 361:226

    Google Scholar 

  97. Vihinen M, Smith CIE (1996) Structural aspects of signal transduction in B cells. Crit Rev Immunol 16:251

    Google Scholar 

  98. Vihinen M, Nilsson L, Smith CIE (1994) Tee homology (TH) adjacent to PH domain. FEBS Lett 350:263

    Google Scholar 

  99. Vihinen M, Vetrie D, Maniar HS, Ochs HD, Zhu Q, Vorechovsky I, Webster ADB, Notarangelo LD, Nilsson L, Sowadski JM, Smith CIE (1994) Structural basis for chromosome X-linked agammaglobulinemia. A tyrosine kinase disease. Proc Natl Acad Sci USA 91:12803

    Google Scholar 

  100. Vihinen M, Cooper MD, De Saint Basile G, et al (1995) BTKbase: a database of XLA-causing mutations. Immunol Today 16:460

    Google Scholar 

  101. Vihinen M, Zvelebil MJJM, Zhu Q, Ochs HD, Brooimans RA, Zegers BMJ, Nilsson L, Waterfield MD, Smith CIE (1995) Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia. Biochemistry 34:1475

    Google Scholar 

  102. Vihinen M, Brooimans, Kwan S-P, Lehväslaiho H, Litman GW, Ochs HD, Resnick I, Schwaber JH, Vorechovsky I, Smith CIE (1996) BTKbase — X-linked agammaglobulinemia mutation registry. Immunol Today 17: 502

    Google Scholar 

  103. Vihinen M, Iwata T, Kinnon C, Kwan S-P, Ochs H, Vorechovsky I, Smith CIE (1996) BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 24:160

    Google Scholar 

  104. Vihinen M, Belohradsky BH, Haire RN, Holinski-Feder E, Kwan S-P, Lapalainen I, Lehväslaiho H, Lester T, Meindl A, Ochs HD, Ollila J, Vorechovsky I, Weiss M, Smith CIE (1997) BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 25:166

    Google Scholar 

  105. Vihinen M, Note B, Mattsson PT, Bäckesjö C-M, Nars M, Koutaniemi S, Watanabe C, Lester T, Jones A, Ochs HD, Smith CIE (1997) Missense mutations affecting a conserved cysteine pair in the TH domain of Btk. FEBS Lett 413:205

    Google Scholar 

  106. Vihinen M, Brandau O, Brandén LJ, Kwan S-P, Lappalainen I, Lester T, Noordzij JG, Ochs HD, Ollila J, Pienaar SM. Riikonen P, Saha BK, Smith CIE (1998) BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res (in press)

  107. Vorechovsky I, Zhou J-N, Hammarström L, Smith CIE, Thomas JD, Paul WE, Notarangelo LD, Bernatowska-Matuszkiewicz E (1993) Absence of xid mutation in X-linked agammaglobulinemia. Lancet 342:552

    Google Scholar 

  108. Vorechovsky I, Vetrie D, Holland J, Bentley DR, Thomas K, Zhou J-N, Notarangelo LD, Plebani A, Fontan G, Ochs HD, Hammarström L, Sideras P, Smith CIE (1994) Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xg21.3-q22. Genomics 21:517

    Google Scholar 

  109. Vorechovsky I, Vetrie D, Merup M, Zhou J-N, Hammarström L, Bentley DR, Smith CIE (1994) A novel protein-tyrosine kinase gene BTK mutated in patients with X-linked agammaglobulinemia: no evidence for DNA rearrangements in B-cell neoplasias. In: Borden EC, Goldman JM, Grignani F (eds) Molecular diagnosis and monitoring of leukemia and lymphoma, vol 2. Challenges of modern medicine. Ares-Serono Symposia Publications, Rome, pp 205–209

    Google Scholar 

  110. Vorechovsky I, Vihinen M, De Saint Basile G, Honsova S, Hammarström L, Müller S, Nilsson L, Fischer A, Smith CIE (1995) DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Hum Mol Genet 4:51

    Google Scholar 

  111. Vorechovsky I, Luo L, De Saint Basile G, Hammarström L, Smith CIE, Webster ADB (1995) Improved oligonucleoride primer set for molecular diagnosis of X-linked agammaglobulinemia. Predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase. Hum Mol Genet 4:2403

    Google Scholar 

  112. Xu W, Harrison SC, Eck MJ (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595

    Google Scholar 

  113. Yel L, Minegishi Y, Coustan-Smith E, Buckley RH, Trübel H, Pachman LM, Kitchingman GR, Campana D, Rohrer J, Conley ME (1996) Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 335:1486

    Google Scholar 

  114. Yao L, Kawakami Y, Kawakami T (1994) The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 91:9175

    Google Scholar 

  115. Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan S-P, Nilsson L, Smith CIE, Witte ON, Chen S-H, Ochs HD (1994) Deletion within the SH3 domain of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J Exp Med 180:461

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for BioTechnology, Department of Biosciences at Novum, Karolinska Institute, S-141 57, Huddinge, Sweden

    C. I. Edvard Smith, Carl-Magnus Bäckesjö, Anna Berglöf, Lars J. Brandén, Tahmina Islam, Pekka T. Mattsson, Abdalla J. Mohamed, Susanne Müller & Beston Nore

  2. Department of Immunology, Microbiology, Pathology and Infectious diseases (IMPI), Huddinge Hospital, Huddinge, Sweden

    C. I. Edvard Smith, Carl-Magnus Bäckesjö, Anna Berglöf, Lars J. Brandén, Tahmina Islam, Abdalla J. Mohamed, Susanne Müller & Beston Nore

  3. Gene Therapy Center, Clinical Research Center, Huddinge Hospital, S-141 57, Huddinge, Sweden

    C. I. Edvard Smith

  4. Department of Biochemistry and Food Chemistry, University of Turku, FIN-20014, Turku, Finland

    Pekka T. Mattsson

  5. Department of Biosciences, Division of Biochemistry, PO Box 56, FIN-00014, Helsinki, Finland

    Mauno Vihinen

Authors
  1. C. I. Edvard Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carl-Magnus Bäckesjö
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Berglöf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars J. Brandén
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tahmina Islam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pekka T. Mattsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Abdalla J. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Susanne Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Beston Nore
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mauno Vihinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, C.I.E., Bäckesjö, CM., Berglöf, A. et al. X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase. Springer Semin Immunopathol 19, 369–381 (1998). https://doi.org/10.1007/BF00792597

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00792597

Keywords

Search

Navigation